SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Proteolix, Inc. Presents Phase 1b/2 Clinical Data for Carfilzomib in Advanced Solid Tumor Patients at the 2009 American Society of Clinical Oncology Annual Meeting